-
Advances of Drug-Loaded Microsphere Technology for Targeted Immunotherapy Against Prostate Cancer
19 Sep 2025 16:43 GMT
… resists conventional treatments. Microcatheter-assisted drug-loaded microspheres … therapy (ADT) drugs, such as leuprolide and goserelin, … as collaboration across clinical medicine, data science, … doi:10.3390/pharmaceutics14020359.
10. Nicoletti R, …
-
Keto, Ivermectin, & Fenbendazole: New Cancer Treatment Protocol Gains Momentum
16 Sep 2025 03:54 GMT
… testosterone suppressant drugs (leuprolide injections and apalutamide pills) until his … known, highly published doctors and medical research professionals.
Here … clinical trials and therefore was not FDA approved, … Kramer’s first treatment for tonsil cancer …
-
How Does Cancer Treatment Affect Menopause and Fertility?
11 Sep 2025 21:01 GMT
… . Elizabeth Sakach, breast medical oncologist at Winship Cancer … premature menopause during cancer treatment, such as fertility preservation … GnRH agonists like Lupron (leuprolide), given in partnership with … now have the POSITIVE trial to guide patients. About …
-
Foresee Pharmaceuticals Announces FDA Approval Of CAMCEVI ETM For The Treatment Of Advanced Prostate Cancer
29 Aug 2025 04:55 GMT
… PRNewswire/ -- Foresee Pharmaceuticals (6576), ("Foresee… Drug Administration (FDA) has approved the New Drug Application (NDA) for CAMCEVI ETM (leuprolide … enrolled, in which treatment with CAMCEVI ETM … Phase 3 clinical trial in premenopausal breast …
-
New Cancer Treatment Protocol: A Success!
05 Sep 2025 07:57 GMT
… testosterone suppressant drugs (leuprolide injections and apalutamide pills) until his … known, highly published doctors and medical research professionals.
Here … clinical trials and therefore was not FDA approved, … Kramer’s first treatment for tonsil cancer …
-
A Month of Breakthroughs: The FDA's Oncology Decisions in August 2025
02 Sep 2025 20:48 GMT
… the ongoing shift toward precision medicine, with accelerated approvals for … the FDA-approved drug spironolactone for the treatment of glioblastoma (GBM). The trial will … the treatment of polycythemia vera (PV).
FDA Approves 3-Month Leuprolide Mesylate …
-
FDA Approved Camcevi ETM New Drug Application for Prostate Cancer
02 Sep 2025 16:45 GMT
… Food and Drug Administration (FDA) has approved the New Drug Application, or … ;camcevi_pi.pdf
“Foresee Pharmaceuticals Announces Successful Topline Results from … .
“CAMCEVI® (leuprolide) 42mg injection emulsion, FDA Approved for Treatment of Advanced Prostate …
-
Lower-Dose Leuprolide Agent Earns FDA Nod for Advanced PC
02 Sep 2025 22:41 GMT
… FDA has approved 21 mg leuprolide mesylate (Camcevi ETM, Foresee Pharmaceuticals … primary efficacy endpoint of medical castration, which was … week 24 of treatment, Foresee Pharmaceuticals announced in a … is an award-winning medical journalist based in Birmingham …
-
FDA updates in urology: August 2025
01 Sep 2025 12:19 GMT
… trial (NCT04010539), which showed that gepotidacin was non-inferior to combined treatment … multiple phase 3 trials, where the … in models of drug resistance. The agent … Pharmaceuticals announced that the FDA had approved a 3-month formulation of leuprolide …